Protein kinase inhibitors

• L01EA: BCR-ABL tyrosine kinase inhibitors
• L01EB: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
• L01EC: B-Raf serine-threonine kinase (BRAF) inhibitors
• L01ED: Anaplastic lymphoma kinase (ALK) inhibitors
• L01EE: Mitogen-activated protein kinase (MEK) inhibitors
• L01EF: Cyclin-dependent kinase (CDK) inhibitors
• L01EG: Mammalian target of rapamycin (mTOR) kinase inhibitors
• L01EH: Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
• L01EJ: Janus-associated kinase (JAK) inhibitors
• L01EK: Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
• L01EL: Bruton's tyrosine kinase (BTK) inhibitors
• L01EM: Phosphatidylinositol-3-kinase (Pi3K) inhibitors
• L01EX: Other protein kinase inhibitors

NOTE: the following reference list is generated automatically and has not yet been verified.
Automatic PUBMED search: ("Protein kinase inhibitors/adverse effects"[Mesh] OR "Protein kinase inhibitors/toxicity"[Mesh]) AND (nephrotoxicity OR "Kidney Diseases/chemically induced"[Mesh] OR "Kidney Diseases/pathology"[Mesh] OR "Kidney Diseases/physiopathology"[Mesh])